July 2024

• Indium In-111 Pentetreotide Injection Kit 3mCi/mL
  Approved: July 1, 2024 – Sun Pharmaceutical Industries, Inc.
  Used for: Diagnosis and Investigation
  Generic for: Octreoscan
• Bupivacaine Liposome Injectable Suspension 133mg/10mL (13.3mg/mL) and 266mg/20mL (13.3mg/mL)
  Approved: July 1, 2024 – Jiangsu Hengrui Pharmaceuticals Co., Ltd.
  Used for: Analgesia
  Generic for: Exparel
• L-Glutamine Powder for Oral Solution 5gm/packet
  Approved: July 8, 2024 – Novitium Pharma LLC
  Used for: Sickle Cell Disease
  Generic for: Endari
• Nimodipine Oral Solution 3mg/mL
  Approved: July 9, 2024 – Annora Pharma Private Limited
  Used for: Subarachnoid Hemorrhage
  Generic for: Nymalize
• Tazarotene Topical Cream 0.05%
  Approved: July 15, 2024 – Padagis Israel Pharmaceuticals Ltd.
  Used for: Plaque Psoriasis
  Generic for: Tazorac Cream 0.05%